Zydus Cadila Vaxirab N 2.5IU Injection
Summary of product characteristics
NAME OF THE MEDICINAL PRODUCT
Rabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM]
PHARMACEUTICAL FORM
Lyophilized vaccine to be reconstituted with accompanying sterile water for injection I.P. for Intramuscular or Intradermal injection
CLINICAL PARTICULARS
Active immunization against rabies.
Lyophilized vaccine to be reconstituted with accompanying sterile water for injection I.P. for Intramuscular or Intradermal injection
- Pre-exposure Prophylaxis (preventive, prior to exposure): Immunization prior to possible infection with rabies, particularly for vets, veterinary medicine students, animal keepers, hunters, forestry workers, animal handlers, butchers, personnel in rabies research laboratories, etc., or prior to visits to areas in which rabies in endemic (rabies infected areas).
- Post exposure Prophylaxis (after exposure): Treatment after contact with animals which are rabid or suspected to be rabid, or after contact with an inoculated rabies carcass.
Posology and method of administration
Lyophilized vaccine to be reconstituted with accompanying sterile water for injection I.P. for Intramuscular or Intradermal injection
Add the diluent (1 ml Sterile Water for Injections I.P) to the Lyophilized vaccine. The vaccine should be visually inspected both before and after reconstitution for any foreign particulate matter and / or change in physical appearance. The vaccine must not be used if any change in the appearance of the vaccine has taken place. A clear solution results after reconstitution of the freeze-dried powder with the clear and colorless diluent.
(source: https://www.zyduslife.com/public/pdf/1_PI%20&%20SmPC_Rabies%20vaccine%20Human%20I.P._VaxiRab%20N%C2%AE.pdf)